StockWatch
·
Biotechnology: Pharmaceutical Preparations
CSRJun 1, 2026, 07:02 AM

Axsome Supports Migraine & Headache Awareness Month Initiatives

AI Summary

Axsome Therapeutics, Inc. is highlighting its commitment to the migraine community by supporting educational initiatives during Migraine and Headache Awareness Month in June. The company is backing the first annual "Headache in the City" campaign by the Headache Alliance on June 15 in New York City. Additionally, Axsome's New York City headquarters at One World Trade Center will be lit in purple on June 4 to promote awareness efforts, and the company is sharing resources from leading migraine advocacy organizations.

Key Highlights

  • Axsome Therapeutics is supporting Migraine and Headache Awareness Month in June.
  • The company is backing the first annual "Headache in the City" educational campaign on June 15 in New York City.
  • Axsome's New York City headquarters, One World Trade Center, will be lit in purple on June 4 for migraine awareness.
  • Axsome is sharing resources from leading migraine advocacy organizations.
  • Migraine affects approximately 40 million people in the U.S.
  • Migraine is the second leading cause of disability worldwide.